Sanofi mulls Lyxumia lixisenatide market positioning with ADA data
27 June 2011
Peter Thornton
Please Login to read the full article.
27 June 2011
Peter Thornton
pthornton@business-insights.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Latest GetGoal positive for Sanofi/Zealand as European regulator mulls lixisenatide
- NICE recommends Lilly's Bydureon, but which GLP-agonist will top UK market?
- GSK's albiglutide GLP-1 agonist hits endpoint in a second PhIII trial
- Zealand finally Gets its Goal as Sanofi files Lyxumia in Europe
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
